ChiCTR-INR-16010046
尚未开始
/
/
/
2016-11-24
/
/
頸部肌筋膜疼痛
保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
随机平行对照
治疗新技术
Randomized control trial
Single-blind: Investigator/research team
Department of Anaesthesia & Intensive Care, Department of Occupational Therapy, PWH
/
90
/
1990-01-01
1990-01-01
/
Consenting adult (age 18-75) with subacute or chronic myofascial neck problem with at least 1 trigger point presents at the neck region, and agrees to discontinue other alternative treatments once giving consent to participate unless approved by the investigators.；
请登录查看Patient refusal, pregnancy, confirmed to be unsuitable to participate by pain specialists due to the presence of urgent or severe co-morbidities or conditions, known severe psychiatric illness, known malignancy, skin disease, infectious disease, severe cardiovascular disease, patients taking anti-coagulants, and patients who are being randomized to receive Bowen therapy (Group 2), receiving concurrent treatment or intervention for pain control such as alternative medicine, physiotherapy, chiropractor, but refuse to discontinue during study period will be excluded.；
请登录查看Department of Anaesthesia & Intensive care, Prince of Wales Hospital, CUHK
/
Department of Anaesthesia & Intensive care, Prince of Wales Hospital, CUHK的其他临床试验
Department of Anaesthesia & Intensive Care, PWH的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10